Clinical trials are studies that help determine whether new health interventions – such as drugs, other therapies, and vaccines – are safe and effective for patients and the public. Vast amounts of data are generated over the course of a clinical trial; however, a large portion is never published in peer-reviewed journals. Data sharing can advance new discoveries and improve clinical care, but at the same time, sharing clinical trial data presents risks, burdens, and challenges, including protecting the privacy and consent of clinical trial participants. A new report from the Institute of Medicine provides recommended guidelines about what data should be shared at key times in a clinical trial.
Advance copies will be available to reporters only beginning at noon EST Tuesday, Jan. 13. The report is embargoed and not for public release before 1 p.m. EST Wednesday, Jan. 14. To obtain a copy, reporters should contact the National Academies’ Office of News and Public Information; tel. 202-334-2138 or e-mail news@nas.edu.
Members of the authoring committee will present the report’s findings and recommendations at a public briefing beginning at 1 p.m. EST Wednesday, Jan. 14, at the National Academy of Sciences building, 2101 Constitution Ave., N.W., Washington, D.C.
Those who cannot attend in person may view a live webcast of the event.